|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 08-03 | Altimmune Begins Patient Enrollment in Phase 3 Pemvidutide Trial for MASH | MT |
| 07-28 | Altimmune, Inc. - Special Call |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +10.00% | +13.39% | +13.88% | +29.03% | +55.95% | +51.99% | +83.45% | -11.03% | - | 56.7B | |
| +0.80% | -7.82% | -12.37% | +8.98% | +1.56% | +24.61% | +60.00% | +179.46% | +5,609.80% | 51.97B | |
| -0.98% | +0.29% | -6.35% | -6.35% | -4.04% | -14.90% | -14.35% | -74.03% | - | 23.33B | |
| +0.30% | -5.71% | -11.51% | -25.90% | -43.26% | -9.15% | +345.82% | +310.77% | +740.43% | 21.34B | |
| +1.73% | -1.57% | +0.51% | +10.86% | -7.35% | +35.40% | -28.62% | -35.29% | +56.24% | 17.44B | |
| +4.29% | +1.67% | -3.39% | +103.90% | +186.76% | +201.24% | +344.48% | +1,496.23% | +687.19% | 14.77B | |
| +1.71% | +0.34% | +0.27% | +28.21% | +27.77% | +50.30% | +169.75% | +229.99% | +496.38% | 13.84B | |
| +4.16% | +4.75% | +6.67% | +19.76% | +34.95% | +462.40% | +177.20% | +34.22% | +1,421.05% | 12.12B | |
| +5.30% | -7.93% | -3.89% | -1.20% | -12.84% | +67.97% | +162.62% | +494.40% | +6,365.73% | 11.14B | |
| +2.83% | -2.49% | -9.11% | +24.09% | +23.72% | +114.25% | +147.98% | +172.67% | +549.67% | 10.38B | |
| +5.48% | +5.00% | -10.77% | -14.61% | -21.33% | -49.17% | +602.04% | +72.65% | +96.62% | 10.41B | |
| +0.12% | +0.01% | +98.58% | +114.92% | +80.15% | +201.22% | +336.77% | +373.52% | - | 8.83B | |
| +10.54% | +4.90% | +21.14% | +51.17% | +220.33% | +545.39% | +705.53% | -33.05% | -9.14% | 8.35B | |
| +2.17% | -1.46% | -6.34% | -3.93% | +18.53% | +65.63% | +12.02% | +144.70% | - | 7.73B | |
| -2.80% | -0.57% | -26.38% | -2.25% | +251.01% | +193.25% | +228.61% | -38.33% | - | 7.49B | |
| +2.59% | -10.38% | -17.01% | +17.30% | +4.29% | +10.30% | +351.45% | +286.82% | - | 7.05B | |
| -1.17% | -3.27% | -1.12% | +17.34% | +7.13% | +10.15% | +65.78% | +8.40% | +210.16% | 7.26B | |
| +10.24% | +5.93% | +10.73% | +16.95% | +20.61% | +275.79% | +254.05% | +585.44% | - | 6.64B | |
| +4.47% | -1.53% | -7.32% | -28.91% | -48.05% | - | - | - | - | 6.41B | |
| Average | +3.38% | -1.18% | +1.91% | +18.91% | +41.89% | +124.26% | +222.48% | +233.20% | +1,474.92% | 15.96B | |
| Weighted average by Cap. | +3.68% | -0.17% | +0.79% | +17.88% | +33.10% | +85.14% | +164.79% | +190.62% | +2,355.26% |
- Stock Market
- Stocks
- ALT Stock
- Stock
- Sector Altimmune Inc
Select your edition
All financial news and data tailored to specific country editions
